Cyclooxygenase inhibition and cardiovascular risk. [Circulation. 2005] - PubMed

loading

Review COX-2 inhibitors and cardiovascular risk. [Prog Cardiovasc Nurs. 2005]
Review COX-2 inhibitors and cardiovascular risk.
Flattery MP, Hylton Gravatt LA. Prog Cardiovasc Nurs. 2005 Summer; 20(3):123-5.
Review The emerging cardiovascular risk profile for nonsteroidal anti-inflammatory drugs: implications for clinical nurse specialist practice. [Clin Nurse Spec. 2006]
Review The emerging cardiovascular risk profile for nonsteroidal anti-inflammatory drugs: implications for clinical nurse specialist practice.
O'Malley P. Clin Nurse Spec. 2006 Nov-Dec; 20(6):277-65.
The cardiovascular risks of etoricoxib (Arcoxia). [Ann Saudi Med. 2008]
The cardiovascular risks of etoricoxib (Arcoxia).
Sasich LD, Barasain MA, Al Kudsi MA. Ann Saudi Med. 2008 Mar-Apr; 28(2):141-2.
COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions? [Expert Opin Drug Saf. 2006]
COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions?
Bannwarth B. Expert Opin Drug Saf. 2006 Jan; 5(1):1-2; author reply 1-2.
The Vioxx debacle revisited. [Am J Med. 2005]
The Vioxx debacle revisited.
Manthous CA. Am J Med. 2005 Sep; 118(9):1056-7; author reply 1057.

Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius. [Sleep Disord. 2012]
Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius.
Daulatzai MA. Sleep Disord. 2012; 2012:251096. Epub 2012 Jan 16.
Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study. [PLoS One. 2013]
Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
Olsen AM, Fosbøl EL, Lindhardsen J, Andersson C, Folke F, Nielsen MB, Køber L, Hansen PR, Torp-Pedersen C, Gislason GH. PLoS One. 2013; 8(1):e54309. Epub 2013 Jan 30.
Helicobacter pylori Infection and Inflammation: Implication for the Pathophysiology of Diabetes and Coronary Heart Disease in Asian Indians. [J. Life Sci.. 2009]
Helicobacter pylori Infection and Inflammation: Implication for the Pathophysiology of Diabetes and Coronary Heart Disease in Asian Indians.
Rahman MA, Cope MB, Sarker SA, Garvey WT, Chaudhury HS, Khaled MA. J. Life Sci.. 2009 Jul; 1(1):45-50.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Cyclooxygenase inhibition and cardiovascular risk.
Cyclooxygenase inhibition and cardiovascular risk.
Circulation. 2005 Aug 2 ;112(5):759-70.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed